Toxic epidermal necrolysis. Treatment with pentoxyifylline
- 1 May 1994
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 130 (5) , 688
- https://doi.org/10.1111/j.1365-2133.1994.tb13130.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five casesArchives of Dermatology, 1992
- Efficacy of cyclophosphamide in toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1991
- T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cellsArchives of Dermatology, 1991
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- OXPENTIFYLLINE IN ENDOTOXAEMIAThe Lancet, 1989
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- TOXIC EPIDERMAL NECROLYSISThe Lancet, 1972
- AN ANALYSIS OF GRAFT-VERSUS-HOST DISEASE IN SYRIAN HAMSTERSThe Journal of Experimental Medicine, 1970
- AN ANALYSIS OF GRAFT-VERSUS-HOST DISEASE IN SYRIAN HAMSTERSThe Journal of Experimental Medicine, 1970